Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline

被引:717
|
作者
Styne, Dennis M. [1 ]
Arslanian, Silva A. [2 ]
Connor, Ellen L. [3 ]
Farooqi, Ismaa Sadaf [4 ]
Murad, M. Hassan [5 ]
Silverstein, Janet H. [6 ]
Yanovski, Jack A. [7 ]
机构
[1] Univ Calif Davis, Sacramento, CA 95817 USA
[2] Univ Pittsburgh, Pittsburgh, PA 15224 USA
[3] Univ Wisconsin, Madison, WI 53792 USA
[4] Univ Cambridge, Cambridge CB2 0QQ, England
[5] Mayo Clin, Rochester, MN 55905 USA
[6] Univ Florida, Gainesville, FL 32607 USA
[7] NIH, Bethesda, MD 20892 USA
来源
关键词
BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; Y GASTRIC BYPASS; QUALITY-OF-LIFE; SUGAR-SWEETENED BEVERAGES; POLYCYSTIC-OVARY-SYNDROME; PLACEBO-CONTROLLED TRIAL; SHORT-SLEEP DURATION; NATIONALLY REPRESENTATIVE SAMPLE; RANDOMIZED CONTROLLED-TRIAL;
D O I
10.1210/jc.2016-2573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cosponsoring Associations: The European Society of Endocrinology and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. Objective: To formulate clinical practice guidelines for the assessment, treatment, and prevention of pediatric obesity. Participants: The participants include an Endocrine Society-appointed Task Force of 6 experts, a methodologist, and a medical writer. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation approach to describe the strength of recommendations and the quality of evidence. The Task Force commissioned 2 systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Endocrine Society committees and members and co-sponsoring organizations reviewed and commented on preliminary drafts of this guideline. Conclusion: Pediatric obesity remains an ongoing serious international health concern affecting; similar to 17% of US children and adolescents, threatening their adult health and longevity. Pediatric obesity has its basis in genetic susceptibilities influenced by a permissive environment starting in utero and extending through childhood and adolescence. Endocrine etiologies for obesity are rare and usually are accompanied by attenuated growth patterns. Pediatric comorbidities are common and long-term health complications often result; screening for comorbidities of obesity should be applied in a hierarchal, logical manner for early identification before more serious complications result. Genetic screening for rare syndromes is indicated only in the presence of specific historical or physical features. The psychological toll of pediatric obesity on the individual and family necessitates screening for mental health issues and counseling as indicated. The prevention of pediatric obesity by promoting healthful diet, activity, and environment should be a primary goal, as achieving effective, long-lasting results with lifestyle modification once obesity occurs is difficult. Although some behavioral and pharmacotherapy studies report modest success, additional research into accessible and effective methods for preventing and treating pediatric obesity is needed. The use of weight loss medications during childhood and adolescence should be restricted to clinical trials. Increasing evidence demonstrates the effectiveness of bariatric surgery in themost seriously affected mature teenagers who have failed lifestyle modification, but the use of surgery requires experienced teams with resources for long-term follow-up. Adolescents undergoing lifestyle therapy, medication regimens, or bariatric surgery for obesity will need cohesive planning to help them effectively transition to adult care, with continued necessary monitoring, support, and intervention. Transition programs for obesity are an uncharted area requiring further research for efficacy. Despite a significant increase in research on pediatric obesity since the initial publication of these guidelines 8 years ago, further study is needed of the genetic and biological factors that increase the risk of weight gain and influence the response to therapeutic interventions. Also needed are more studies to better understand the genetic and biological factors that cause an obese individual to manifest one comorbidity vs another or to be free of comorbidities. Furthermore, continued investigation into the most effective methods of preventing and treating obesity and into methods for changing environmental and economic factors that will lead to worldwide cultural changes in diet and activity should be priorities. Particular attention to determining ways to effect systemic changes in food environments and total dailymobility, as well as methods for sustaining healthy bodymass index changes, is of importance.
引用
收藏
页码:709 / 757
页数:49
相关论文
共 50 条
  • [1] Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline
    Styne, Dennis
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 5 - 5
  • [2] Letter to the Editor: "Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline"
    Ball, Geoff D. C.
    Perez, Arnaldo
    Nobles, James D.
    Spence, Nicholas D.
    Skelton, Joseph A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (06): : 2121 - 2122
  • [3] Response to Letter: "Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline"
    Styne, Dennis M.
    Arslanian, Silva A.
    Connor, Ellen L.
    Farooqi, Ismaa Sadaf
    Murad, M. Hassan
    Silverstein, Janet H.
    Yanovski, Jack A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (06): : 2123 - 2124
  • [4] Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion
    August, Gilbert P.
    Caprio, Sonia
    Fennoy, Ilene
    Freemark, Michael
    Kaufman, Francine R.
    Lustig, Robert H.
    Silverstein, Janet H.
    Speiser, Phyllis W.
    Styne, Dennis M.
    Montori, Victor M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (12): : 4576 - 4599
  • [5] Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion (vol 93, pg 4576, 2008)
    August, G. P.
    Caprio, S.
    Fennoy, I
    Freemark, M.
    Kaufman, F. R.
    Lustig, R. H.
    Silverstein, J. H.
    Speiser, P. W.
    Styne, D. M.
    Montori, V. M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (07): : E2846 - E2846
  • [6] Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
    Apovian, Caroline M
    Aronne, Louis J.
    Bessesen, Daniel H.
    McDonnell, Marie E.
    Murad, M. Hassan
    Pagotto, Uberto
    Ryan, Donna H.
    Still, Christopher D.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : 342 - 362
  • [7] Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
    Holick, Michael F.
    Binkley, Neil C.
    Bischoff-Ferrari, Heike A.
    Gordon, Catherine M.
    Hanley, David A.
    Heaney, Robert P.
    Murad, M. Hassan
    Weaver, Connie M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07): : 1911 - 1930
  • [8] Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline
    Hembree, Wylie C.
    Cohen-Kettenis, Peggy
    Delemarre-van de Waal, Henriette A.
    Gooren, Louis J.
    Meyer, Walter J., III
    Spack, Norman P.
    Tangpricha, Vin
    Montori, Victor M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (09): : 3132 - 3154
  • [9] Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
    Demay, Marie B.
    Pittas, Anastassios G.
    Bikle, Daniel D.
    Diab, Dima L.
    Kiely, Mairead E.
    Lazaretti-Castro, Marise
    Lips, Paul
    Mitchell, Deborah M.
    Murad, M. Hassan
    Powers, Shelley
    Rao, Sudhaker D.
    Scragg, Robert
    Tayek, John A.
    Valent, Amy M.
    Walsh, Judith M. E.
    Mccartney, Christopher R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (08): : 1907 - 1947
  • [10] Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline
    Stuenkel, Cynthia A.
    Davis, Susan R.
    Gompel, Anne
    Lumsden, Mary Ann
    Murad, M. Hassan
    Pinkerton, Joann V.
    Santen, Richard J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11): : 3975 - 4011